MPWT
VERV

MassMutual Private Wealth & Trust’s Verve Therapeutics VERV Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22
Closed -$292 – 2100
2023
Q3 		$292 Buy
+22
New +$354 ﹤0.01% 1896

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

MassMutual Private Wealth & Trust's VERV Position: Q4 2023 in Review

MassMutual Private Wealth & Trust sold out of Verve Therapeutics (VERV) in Q4 2023, closing a stake of 22 shares — an estimated $292 sold.

MassMutual Private Wealth & Trust first reported a position in VERV in Q3 2023 and held it in 1 quarter. The position peaked at $292 in Q3 2023. 157 funds tracked by Wall St. Rank hold VERV as of Q4 2023.

  • MassMutual Private Wealth & Trust reported no remaining Verve Therapeutics position as of Q4 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 22 Verve Therapeutics shares in Q4 2023, an estimated $292.
  • MassMutual Private Wealth & Trust first reported a position in Verve Therapeutics in Q3 2023 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Verve Therapeutics position peaked at $292 in Q3 2023.
  • 157 funds tracked by Wall St. Rank held Verve Therapeutics as of Q4 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2023, filed 3 Jan 2024.